gener price stabil valuat
prompt upgrad buy
upgrad buy hold given belief combin
stabil gener drug price stock discount valuat vs
peer healthi yield lesser extent consensu ep bump
reflect tax reform boost investor interest year push stock
multipl appropri level translat upsid current
stabil gener price drive multipl expans hold rate
predic view gener price uncertainti go drag
earn perform valuat throughout highlight note
proprietari analysi gener price point emerg stabil trend first
month price stabil last yr believ persist throughout
pave way multipl expans improv earn lt margin
exposur tangibl risk fairli minim continu believ
moment healthcar plan includ entri pharmaci space
focu current med suppli devic updat thought highlight
note exposur med suppli fairli minim ebitda vs
peer exampl expect volatil headlin risk fairli mute
name
believ street ep estim low analyst adjust
estim tax reform benefit redeploy cash tax save
like fund buyback fulli reflect street ep could see upward bia
estim take account lower tax rate expect buyback
set ep current consensu
gener price stabil benefit three
distributor chose upgrad given valuat low med supplies/amzn risk
rais pt earn volatil result persist gener price
pressur dissip believ see valuat trend close line
histor level average price-to-earnings discount vs yet stock
current trade discount rais pt deriv appli
histor pe/g ratio differenti vs well absolut price-to-earnings delta vs
 tax reform-adjust ep risk headlin risk
hold
pleas see analyst certif import disclosur inform inform regard statu non-u analyst page report
gener sell-sid environ remain rel
stabl claruson continu see scale benefit
flow cog line see improv earn
perform multipl expans
exposur medic suppli fairli minim
expect volatil headlin risk fairli
mute name
earn volatil result persist gener
price pressur dissip believ see
valuat trend close line histor level
magnitud number brand drug price increas
monthli sell-sid gener brand price read-out
sell-sid gener deflat stabil low-mid singl
digit marketplac remain ration price
brand inflat continu moder mid-high-
claruson continu drive gener purchas
effici
reduc earn volatil
equiti invest continu accret
discount pe/g pt
sell-sid gener deflat subsid substanti
claruson abl gener addit purchas
leverag product categori
brand inflat stabil high-singl digit number
brand drug price increas normal
synergi greater anticip
materi impact medic distribut
gener deflat re-acceler low-doubl digit
marketplac competit heighten
brand inflat continu moder mid-singl
digit manufactur choos increas price
chang healthcar synergi lower expect
and/or ipo exit timet extend
enter rx and/or medic distribut space
page
pleas see import disclosur inform page report
stabil persist throughout
pave way multipl
expans improv earn
perform
initi coverag hold rate may primarili due view
gener price uncertainti go drag earn perform
stock valuat throughout thesi play recent analysi
gener price data detail note publish yesterday indic sell-
side gener price within proprietari basket gener ndc roughli flat m/m
exhibit fifth month gener stabil last six base
data well channel check convers
differ drug distributor manag team expect sell-sid gener price stabil
persist throughout pave way multipl expans improv
earn perform
start sept gener deflat began acceler
rel stabl sinc may exhibit fact sell-sid gener price
within basket experienc deflat sinc may lowest level
deflat period sinc
page
pleas see import disclosur inform page report
magnitud neg y/i gener price chang decreas slightli vs
prior month
compar number y/i price decreas oct percentag
neg gener drug price chang slightli vs oct
magnitud gener price decreas excess also lower
vs oct vs
gener price spread stabil even slightli improv
exhibit illustr sell-sid gener price continu stabil
conserv assum q/q deflat gener manufactur continu
see upper-single/low doubl digit price deflat see
gener spread stabil even slightli improv y/i claruson benefit
translat improv margin perform
stabil assum
q/q deflat gener
manufactur continu see
deflat
see gener spread
benefit
page
pleas see import disclosur inform page report
 prescript within price chang rangeoct gener deflat expectationsgener drug basket y/i changeproject y/i chang q/q deflat realiz y/i changebuy-sid gener deflat endbuy-sid gener deflat high end
exposur medic suppli
fairli minim vs peer
exampl expect volatil
headlin risk fairli
mute name
mck exposur tangibl risk fairli minim
laid recent note continu believ moment
healthcar plan includ entri pharmaci space focu
current medic suppli devic fact recent review amzn wholesal
med device/suppli distribut licens found begun let licens
expir two three exist med device/suppli distribut center plainfield
whitestown full licens inform exhibit exposur medic
suppli fairli minim ebitda vs peer exampl expect
volatil headlin risk fairli mute name
estim tax reform
result least
ep
annual save
tax reform fulli bake stock upcom quantif
wont like give estim tax benefit number earn call
feb estim tax reform result least
ep annual tax save
moment four sell-sid analyst updat estim incorpor benefit
tax reform believ upcom quantif still drive ep estim
higher impli upsid estim exhibit provid modest nt
increment lift stock
exhibit ep upsid tax reform
page
pleas see import disclosur inform page report
